Fingerprint
Dive into the research topics of 'Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: A phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: A phase 2 trial
Kent A. Robertson, Grzegorz Nalepa, Feng Chun Yang, Daniel C. Bowers, Chang Y. Ho, Gary D. Hutchins, James M. Croop, Terry A. Vik, Scott C. Denne, Luis F. Parada, Cynthia M. Hingtgen, Laurence E. Walsh, Menggang Yu, Kamnesh R. Pradhan, Mary K. Edwards-Brown, Mervyn D. Cohen, James W. Fletcher, Jeffrey B. Travers, Karl W. Staser, Melissa W. Lee
Research output: Contribution to journal › Article › peer-review
186
Scopus
citations